Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 29, 2016 16:01 ET | Source: Kite Pharma, Inc.

Kite Pharma Reports Fourth Quarter and Full-Year 2015 Financial Results

- Interim KTE-C19 Data, Expected in Second Half of 2016, to Support Planned BLA Filing in Late 2016 and Potential Product Launch in 2017 - ...
February 24, 2016 17:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Augments Commercial Leadership Team

SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™)...
February 24, 2016 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016

SANTA MONICA, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report fourth quarter and full year 2015 financial results on Monday,...
February 16, 2016 16:31 ET | Source: Kite Pharma, Inc.

Kite Pharma to Participate in the 2016 RBC Capital Markets Global Healthcare Conference

SANTA MONICA, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that David D. Chang, M.D., Ph.D., Executive Vice President, Research and Development,...
January 13, 2016 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma and Leiden University Medical Center Sign Research and License Agreement for T Cell Receptors Targeting HPV-Associated Cancers

SANTA MONICA, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that its European subsidiary has entered into a research and license agreement with Leiden...
January 07, 2016 10:26 ET | Source: Kite Pharma, Inc.

Kite Pharma Expands Its Clinical and Research Partnership With the National Cancer Institute (NCI) for Next-Generation CAR Programs to Treat B-Cell Malignancies

SANTA MONICA, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI...
January 06, 2016 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will...
December 21, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Appoints Industry Leader Shawn Cline Tomasello as Chief Commercial Officer

SANTA MONICA, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (NASDAQ:KITE) today announced that it has appointed Shawn Tomasello to the newly created position of Chief Commercial...
December 11, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

SANTA MONICA, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that the underwriters of its previously announced underwritten public offering have exercised...
December 10, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Pricing of Public Offering of Common Stock

SANTA MONICA, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced the pricing of an underwritten public offering of 3,625,000 shares of its common stock at a...